Apparently awaiting r & d tax refund. That’ll keep the lifeline going. But you’re right in that if we don’t sign bluescope we sink.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025